In addition, CCL22 promotes the migration of regulatory T cells (Tregs) through the CCR4 receptor25,26, and VEGF-A in addition to its angiogenic effects exerts immunosuppressive effects leading to the accumulation of Tregs and myeloid-derived suppressor cells in the tumor microenvironment27. This evidence concerns the gene VEGFA and neoplasm.